Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Point of Care Diagnostics - Economic Reimbursement & Technology Trends

24 Oct 2012 - 25 Oct 2012 - London, UK



Bookmark and Share


SMi present their 9th annual Point of Care Diagnostics conference, which will bring together key members of the diagnostics and healthcare industries to discuss the implementation of technology, the reimbursements of the industry, and the connectivity of point of care technology throughout Europe and the world.

Benefits of Attending:

· Network with diagnostic manufacturers, pharmaceutical specialists and key healthcare practitioners working with POC technology

· Explore the economics, market developments, connectivity and the controversial topics of the POC industry

· Learn about the current market pulls and emerging technologies, and the ways they affect the medical diagnostics industry

· Discuss the POC industry, its potential expansion into wider markets and its future in the NHS and in European healthcare

· Consider new emerging technologies, and speak to the industry leaders at the forefront of development, manufacture and usage

Keynote Speakers include:

· Thomas Li, Senior Director, Technology Management, Roche Diagnostics, Singapore 

· Hans Winkler, Senior Director, Biomarkers, Janssen R&D (a Johnson & Johnson company) 

· David Huckle, President & Director General, ABA – France 

· Gilbert Greub, Chief of Medicine, Institute of Microbiology 

· Christopher Lowe, Director of the Institute of Biotechnology, University of Cambridge 

PLUS 2 INTERACTIVE HALF-DAY PRE-CONFERENCE WORKSHOPS 

Tuesday 23rd of October, 2012, Copthorne Tara Hotel, London

A: Health economics, reimbursement, and market access for POC technologies

Workshop Leader: Kuo Tong, President & Founder, Quorum Consulting

8:30 – 12:30

B: The Future of Healthcare: Connecting the vision

Workshop leader: Simon Burnell, Partner, PA Consulting

13:30 – 17:30 pm

***Book before 31st May 2012 and save £300***

***Book before 29th June 2012 and save £100***

Visit our website here: http://www.smi-online.co.uk/goto/2012pointofcare8.asp

Alternatively Contact Shilan Chandi on tel: +44 (0) 20 7827 6738 or email: schandi@smi-online.co.uk



Further information
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!